$61.26
5.119.1%
Últ. Act.: Oct 26, 4:00 PM
GeneDx Holdings (WGS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GeneDx Holdings (WGS) publicó su última previsión de agosto 3, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $475M - $490M para el período.
En comparación con la previsión anterior, GeneDx Holdings mantenido redujo su previsión de ingresos desde un rango anterior de $475M - $490M.
GeneDx Holdings ha emitido 18 actualizaciones de orientación entre el marzo 14, 2023 y el agosto 3, 2026. During this period, the company raised its outlook 9 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.03 | $0.12 | $0.37 |
| Actual | $0.01 | $-0.28 | $0.14 | $0.49 |
| Surprise | +105.3% | -833.3% | +16.7% | +32.4% |
| Revenue | ||||
| Estimate | $110.7M | $112.1M | $119.9M | $104.3M |
| Actual | $114.4M | $102.3M | $121.0M | $116.7M |
| Surprise | +3.33% | -8.71% | +0.87% | +11.9% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.32 | $0.10 | $0.25 |
| Revenue | ||||
| Consensus | $122.8M | $142.0M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $0.01 | $-0.19 | 105.3 % |
| Q1 | May 4, 2026 | $-0.28 | $-0.03 | -833.3 % |
| Q4 | Feb 23, 2026 | $0.14 | $0.12 | 16.7 % |
| Q3 | Oct 28, 2025 | $0.49 | $0.37 | 32.4 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $114.44M | $110.75M | 3.33 % |
| Q1 | May 4, 2026 | $102.30M | $112.06M | -8.71 % |
| Q4 | Feb 23, 2026 | $120.99M | $119.94M | 0.87 % |
| Q3 | Oct 28, 2025 | $116.74M | $104.32M | 11.9 % |